Aisling Capital’s Aravive, Inc. Common Stock ARAV Stock Holding History

Aisling Capital’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-337,411	Closed	-$35.3M	–	15
2017 Q2	$35.3M	Hold	337,411	–	–	6.05%	5
2017 Q1	$43.2M	Sell	337,411 -83,333	-20%	-$8.79M	7.87%	5
2016 Q4	$37.6M	Hold	420,744	–	–	8.74%	4
2016 Q3	$30.9M	Buy	420,744 +40,816	+11%	+$2.95M	6.37%	6
2016 Q2	$25.2M	Hold	379,928	–	–	5.95%	5
2016 Q1	$18.3M	Hold	379,928	–	–	3.66%	13
2015 Q4	$28.2M	Hold	379,928	–	–	4.87%	10
2015 Q3	$26.3M	Hold	379,928	–	–	4.62%	8
2015 Q2	$34.7M	Hold	379,928	–	–	5.17%	7
2015 Q1	$41.9M	Buy	379,928 +47,500	+14%	+$5.57M	5.48%	5
2014 Q4	$44.8M	Hold	332,428	–	–	6.79%	7
2014 Q3	$37.9M	Hold	332,428	–	–	7.35%	7
2014 Q2	$55.9M	Buy	+332,428	New	+$57.4M	16.17%	1

Other funds holding ARAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aisling Capital's ARAV Position: Q3 2017 in Review

Aisling Capital sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2017, closing a stake of 337,411 shares — an estimated $35.3M sold.

Aisling Capital first reported a position in ARAV in Q2 2014 and held it in 13 quarters. The position peaked at $55.9M in Q2 2014. 105 funds tracked by Wall St. Rank hold ARAV as of Q3 2017.

Aisling Capital reported no remaining Aravive, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Aisling Capital sold 337,411 Aravive, Inc. Common Stock shares in Q3 2017, an estimated $35.3M.
Aisling Capital first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 13 quarters.
Aisling Capital's Aravive, Inc. Common Stock position peaked at $55.9M in Q2 2014.
105 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2017.

Based on Aisling Capital's 13F filing for Q3 2017, filed 9 Nov 2017.